By using our website, you are agreeing to cookies being stored and Google Analytics being used on your device in order to offer the best possible service. You can find more information on thishere.
Austria.
Where Your Profits Grow Sky High.

Vahle “think tank“ in Kufstein

Vahle building © Vahle Deto

In the future the Kufstein site will serve as the center for the automation segment of the group and control a significant share of the coordination work. The site in Tyrol sees itself as a “think tank”. The company stated that the good education of potential local employees was a key reason for relocating to Tyrol. A total of EUR 3.2 million was invested in the facility. The family-owned Vahle Group of Germany is a specialist for individual energy and data transmission systems for mobile industrial applications across a broad range of uses and around the world.

Share on Facebook Share on Facebook Share on Twitter Share on Twitter Share on Linkedin Share on Linkedin

Testimonials

Events

Meet us at events, seminars and trade shows - worldwide.

  • ABA's Open Day 2021: Austria - Your ICT and Innovation Hub in the Heart of Europe

    11 March 2021/ 09.00am + 05.00 pm, Online Conference

  • Meet us @ International Machinery Forum 2021 - The Factory of Tomorrow

    11.03 - 12.03 2021, Online Conference

Austria Map

Find the perfect location for your company

Inspite of higher labor costs, the productivity of Siemens Villach is comparable to other Siemens susidiaries in Japan or the USA.

Siemens Austria

Logo
More testimonials

news from the business location Austria

OMV and Kommunalkredit invest in the production of green hydrogen

The Austrian oil and gas company OMV and Kommunalkredit Austria AG (Kommunalkredit) have announced a joint investment in the construction of Austria’s largest electrolysis plant to be located in the OMV Schwechat Refinery.

Evotec SE

Evotec is an active substance research company which rapidly presses ahead with innovative product approaches on the basis of development partnerships with leading pharmaceutical and biotechnology companies, academics, patient advocacy groups and venture capitalists.

More news All blog posts